Company research / Focus view

Aurobindo Pharma

AUROPHARMA · Pharma & Healthcare · mid cap · Midcap 50

Revenue · FY26

₹33,385 cr

+6.4% YoY

What the business sold

Net profit · FY26

₹3,505 cr

+0.5% YoY

What it kept after tax

Operating profit · FY26

₹5,193 cr

+2.9% YoY

Profit from operations

Operating cash flow · FY26

₹5,526 cr

+40.8% YoY

Cash the operations produced

Total debt · FY26

₹8,073 cr

-2.3% YoY

Borrowings against the business

Dividend per share · FY26

—

Paid out per share · not collected yet

Five years in perspective

Price index · Start = 100 · Dividends excluded · ₹1,679.8 today (+0.68%)

+126.5% · 5Y

2021 · 10020222023202420252026 · 243.7

1M +1.3%6M +28.7%1Y +51.4%3Y +93.6%5Y +126.5%

Market cap

₹96,652 Cr

As of 13 Sept 2026

Price to earnings

26.2

Price to book 2.6

Dividend yield

24.00%

Trailing twelve months

52-week range

₹1,067 – ₹1,717

Closing prices

The financial record

₹ crore · Consolidated where reported · Indian fiscal years (April–March)

Reported metric	FY23	FY24	FY25	FY26
Revenue	24,617	28,705	31,378	33,385
Operating profit	2,538	4,442	5,048	5,193
Net profit	1,928	3,173	3,486	3,505
Operating cash flow	2,387	2,435	3,925	5,526
Free cash flow	-334	-1,127	1,405	2,422
Capital expenditure	-2,720	-3,562	-2,520	-3,105
Tax expense	685	1,211	1,583	1,609
Total debt	5,286	6,648	8,263	8,073
Cash and equivalents	4,396	3,393	5,569	7,191
Shareholders equity	26,840	29,843	32,653	37,891
Earnings per share (₹)	32.90	54.16	59.81	60.34

Not collected yet for this company: Dividend per share. These come from the filings, not the daily price feed.

Recent quarters

₹ crore · Most recent first

Quarter ended	Revenue	Operating profit	Net profit	EPS (₹)
30 Jun 2026	9,106	1,394	1,033	17.86
31 Mar 2026	8,752	1,322	921	15.86
31 Dec 2025	8,605	1,309	910	15.67
30 Jun 2025	7,792	1,198	825	14.20
31 Mar 2025	8,381	1,347	903	15.56

Developments

0 positive · 1 negative

NeutralEarningsyesterday

Aurobindo Pharma AGM results: ₹4 dividend confirmed, K. Nithyananda Reddy reappointed amid dissent

Aurobindo Pharmamid cap

scanx.trade13 Sept 2026, 11:53 am IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralM&A2 days ago

Aurobindo Pharma acquires 100% stake in A1 Biochem USA for $1 million

Aurobindo Pharmamid cap

scanx.trade12 Sept 2026, 1:17 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralM&A2 days ago

AUROBINDO PHARMA: Acquires 100% Stake in US Subsidiary

Aurobindo Pharmamid cap

InvestyWise12 Sept 2026, 12:53 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Aurobindo Pharma AUROPHARMA: A1 Biochem USA Inc Setup

Aurobindo Pharmamid cap

Kalkine India12 Sept 2026, 12:41 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Aurobindo Pharma adds Emkay Global meeting to September 17 schedule

Aurobindo Pharmamid cap

scanx.trade11 Sept 2026, 9:56 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralRegulatory3 days ago

Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11

Aurobindo Pharmamid cap

TradingView11 Sept 2026, 8:03 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Reads negativeRegulatory3 days ago

AUROBINDO PHARMA: US FDA Inspection at API Unit Concludes with Zero Observations

Aurobindo Pharmamid cap

InvestyWise11 Sept 2026, 6:31 pm IST

Classification & context · Moves the numbers

The headline states a business fact and a direction that hurts it. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.80. This is not the probability that the report is true.

NeutralRegulatory3 days ago

Aurobindo Pharma Gets Clean USFDA Inspection Report

Aurobindo Pharmamid cap

Equitypandit11 Sept 2026, 6:20 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralRegulatory3 days ago

Aurobindo Pharma gets zero observations from US FDA inspection at Andhra Pradesh facility

Aurobindo Pharmamid cap

CNBC TV1811 Sept 2026, 6:15 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Aurobindo Pharma to attend Bank of America Asia Pacific conference

Aurobindo Pharmamid cap

scanx.trade11 Sept 2026, 5:55 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Aurobindo Pharma to participate in J.P. Morgan India Investor Conference on September 22

Aurobindo Pharmamid cap GAIL (India)Mentioned

scanx.trade11 Sept 2026, 5:49 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Aurobindo Pharma to Join ICICI Securities Investor Meeting on September 17

Aurobindo Pharmamid cap

TipRanks11 Sept 2026, 1:33 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral4 days ago

US Generics Stock Up 53% in 1 Year: Why It Rallied

Aurobindo Pharmamid cap

Univest10 Sept 2026, 8:42 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral4 days ago

Indices trade with minor losses; pharma shares decline

Aurobindo Pharmamid cap

Business Standard10 Sept 2026, 10:50 am IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralEarnings5 days ago

Aurobindo Pharma Q2 FY27: Date and Expectations

Aurobindo Pharmamid cap

Univest9 Sept 2026, 2:45 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralDividend5 days ago

Upcoming Stock Split, Dividend, Bonus Issue THIS Week: Aurobindo Pharma, Muthoot Finance, More | Full List

Aurobindo Pharmamid cap Muthoot FinanceMentioned

Goodreturns9 Sept 2026, 12:30 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Aurobindo Pharma Ltd soars 1.19%

Aurobindo Pharmamid cap

Business Standard8 Sept 2026, 2:50 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Sensex Today | Stock Market Live: Sensex falls 470 pts, Nifty below 23,700; banks, Oil & Gas drag, m

Aurobindo Pharmamid cap

IndiaIPO8 Sept 2026, 12:37 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

About the business

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Industry: Drug Manufacturers - Specialty & Generic

www.aurobindo.com

Data confidence

Prices, fundamentals and developments last verified 13 Sept 2026. Fundamentals are sourced from public filings feeds; interpretation is shown separately from figures.

See the Pharma & Healthcare sector →

Sign in to see the full financial record and classified developments

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.